Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.01 USD | -0.74% | -8.77% | -37.18% |
May. 01 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
May. 01 | Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024 |
Financials (USD)
Sales 2024 * | 82.92M | Sales 2025 * | 98.71M | Capitalization | 313M |
---|---|---|---|---|---|
Net income 2024 * | -65M | Net income 2025 * | -61M | EV / Sales 2024 * | 3.78 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.17 x |
P/E ratio 2024 * |
-4.78
x | P/E ratio 2025 * |
-5.13
x | Employees | 279 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95% |
Latest transcript on Pulmonx Corporation
1 day | -0.74% | ||
1 week | -8.77% | ||
Current month | +5.26% | ||
1 month | +10.03% | ||
3 months | -14.42% | ||
6 months | -27.45% | ||
Current year | -37.18% |
Managers | Title | Age | Since |
---|---|---|---|
Ryan Olivera
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 07-12-31 | |
Lauren Cristina
ADM | Chief Administrative Officer | - | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Ferrari
BRD | Director/Board Member | 70 | 07-01-31 |
Glendon French
BRD | Director/Board Member | 62 | 14-12-17 |
Dana Mead
CHM | Chairman | 64 | 10-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - | |
0.00% | 1,487 M€ | +8.80% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 8.01 | -0.74% | 185,529 |
24-05-24 | 8.07 | -3.70% | 272,255 |
24-05-23 | 8.38 | -6.37% | 158,994 |
24-05-22 | 8.95 | +1.94% | 115,847 |
24-05-21 | 8.78 | -1.57% | 156,581 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.18% | 313M | |
+75.56% | 12.55B | |
-23.35% | 7.51B | |
+8.51% | 6.74B | |
+14.95% | 5.48B | |
-14.65% | 4.93B | |
+30.59% | 4.71B | |
-25.41% | 3.83B | |
-22.61% | 2.9B | |
+49.50% | 2.49B |
- Stock Market
- Equities
- LUNG Stock